Market revenue in 2021 | USD 49.1 million |
Market revenue in 2030 | USD 111.1 million |
Growth rate | 9.5% (CAGR from 2021 to 2030) |
Largest segment | Clinical |
Fastest growing segment | Clinical |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Preclinical, Clinical |
Key market players worldwide | Labcorp Holdings Inc, IQVIA Holdings Inc, Syneos Health, SGS AG, Toxikon, Intertek Group PLC, Pace Analytical Services, Icon PLC, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to large molecule bioanalytical testing services market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 67.21% in 2021. Horizon Databook has segmented the Spain large molecule bioanalytical testing services market based on preclinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.
The Spanish large molecule bioanalytical testing market is driven by the growing number of clinical trials in the country. For instance, Spain conducted 23,369 clinical trials between 1999 and 2019, according to WHO’s ICTRP. This contributes for over 4% of total clinical trials conducted globally in the same period.
Furthermore, according to Eurostat, the healthcare expenditure of Spain was 8.9% of its GDP in 2017. Rising healthcare expenditure will drive the large molecule bioanalytical testing market as well. In 2019, the Spanish Pharmaceutical R&D expenditure rose by 5.2%. The rising pharmaceutical R&D expenditure in the country will also boost market growth.
Furthermore, high geriatric population will augment the need for advanced health care services, driving the Spanish market. For instance, according to OECD, 19.3% of the Spanish population was aged 65 or above in 2018.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain large molecule bioanalytical testing services market , including forecasts for subscribers. This country databook contains high-level insights into Spain large molecule bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account